World News Today, Current News, Breaking News, Business News
World News Today, Current News, Breaking News, Business News, Moon and Mars, Shopping Tips, Beauty Tips and Fashion news

Hair Thinning - Beauty Tips

Category: , By News Updates
Hair thinning is caused by various reasons like medication and illness and often hereditary causes. Most of the times men suffers from this problem. The reasons behind this fact is none other than hormone. Statistics show that most of the men who have reached the age of 50 or are more than that either suffer from baldness or hair thinning. Thankfully there are many treatments that are available to treat hair thinning. The first step involves in consulting a good doctor who will help in identifying the causes of hair thinning and recommend medicines that will address the causes. Focusing on the proper treatment will stop hair thinning.

4 Easy tips to combat hair thinning

Coloring:

If you have inherited the problem of hair thinning, then you must be cautious with your hair. You can use either semi-permanent or permanent color to provide the hair a body and add volume to it, which is extremely important. If your are experiencing because of medicinal side effects semi permanent color can be a good option for you. Strong medications contribute in weakening hair that causes in breaking or falling out. A semi permanent hair is free from ammonia or peroxide. It protects the hair and adds great deal of volume and body to the hair. For fine textured hair a permanent or semi permanent color is good if it is applied with proper professional care. This is because colored hair has the tendency to get over-processed that can damage the hair and cause more hair loss .

Voluming products:

Another way of combating hair thinning is to use voluming products that are available in the market. The products are made with paraffin, extracted from beeswax . To some extent it is not good for hair because sometimes it gets build up in the hair follicles and causes hair to break. However, you can try those voluming products used in salons as they help to a great extent. The products don't weight your hair and does not damage the hair. For example, you can apply mousse to the root to provide necessary support. In the next step blow-dry the root area for extra support. To hold the hair better you can apply a light finishing spray.

Wash your hair daily:

Whenever you feel that your hair is dirty, shampoo your hair and condition your hair from time to time. The dirt and dust of the hair that sticks to your hair tends to make the hair follicles weak and make them fall. Thus, washing your hair from time to time prevents the dirt and dust from accumulating. Use a good quality shampoo and voluming hair conditioner so that the hair is well taken care of.

Select the right hair style:

Find a hairstyle that helps in giving a volume look to your hair. While styling make sure that the hair is not exposed to prolonged heat directly as they will make the hair more brittle and result in thinning. It is advisable not to go for curling irons and flat irons.
 

Hair Loss - Beauty Tips

Category: , By News Updates
Hair loss has become a perennial problem. The amount of hair lost is not supplemented with the number of hair grown. Hence there becomes a problem. Almost all women face a problem with hair loss. A study has said that on a daily basis we lose 100 hairs. The life span of a hair is not more than four years. There can be several reasons for hair loss. The problem can be hereditary, stress or any disease. There is specific treatment for hair loss. But we should not ignore the problem of hair loss. Let us focus on the different causes of hair loss.

Hair Loss

The cause can be hereditary

Little disorder in genetic factor can be the reason for hair loss. Once a hair is lost it gets replaced naturally. But a disorder in genetic factors will not let the lost hair get replaced. The gap gets created. Thus it leads to baldness at a very young age too. There are three other factors which affect hair loss; they are age, gender and hormone. Due to age people loose hair and it might lead to baldness. The problem can be related to hormones too. The problem of hair fall affects men more when compared with women.

The problem could be stress

Stress is another reason for hair loss. Physical stress or emotional stress both contribute to hair loss. There can be 2 type of hair loss in this scenario: Telogen effluvium and Alopecia areata. Telogen effluvium is a severe problem. The hair falls and the growth is almost lost. Hence the gap cannot be filled. Alopecia areata happens when the white blood cells attack the follicles of the hair. In this scenario, the body hair also falls. The hair does grow back but intensive treatment is required. The hair will falls in patches.

Side effects of medicines

Few medicines have side effects. The intake of the medicine results in hair fall. The severity of the medicines is the key factor for hair loss. Like after chemotherapy people tend to lose hair. Even after pregnancy there is a chance of hair fall. As there is a hormonal change during pregnancy there is a chance of hair loss. Birth control pills also lead to hair fall.
 

South Korea police chief resigns over murder outcry

Category: By News Updates
South Korea's police chief has resigned amid an outcry over the case of a woman who was raped and murdered despite calling police for help.


Cho Hyun-oh said he was stepping down to take full responsibility for what he called the "unpardonable carelessness" of his officers. 

The woman told police where she was being held in a seven-minute call to the emergency number. 

Police only found her dismembered body 13 hours after she called for help.

The incident took place on 2 April in Suwon, south of Seoul.

Local media reports said that the woman described in detail landmarks such as a primary school and a playground around the apartment where she was being attacked, but officers failed to find her in time.

"I express my deepest regret at the police's negligence which had such a horrendous result and attempts to cover it up with lies," said Mr Cho, who is the commissioner of the National Police Agency.

Communication mistakes between emergency operators and officers meant that police were searching the wrong area, police have said. 

When public concern was raised, they also inflated the number of officers who had been sent to search the area, local reports said.

President Lee Myung-bak has accepted Mr Cho's resignation.

A man has been arrested in connection with the case.
 

A life-saver for a weak heart sufferers

Category: By News Updates
Sean Rodgers can feel his heart pounding during his marathon-training run - a reminder of how close to death he has come. The 43-year-old suffers from a dangerously abnormal heart rhythm that led, almost two years ago, to a cardiac arrest at his South Yorkshire home. It took 15 minutes for paramedics to shock him back to life using defibrillator paddles. 
weak heart sufferers

Yet this spring, he plans to complete both the London and Edinburgh marathons, while pioneering a new life-saving technology, implanted in the skin under his arm. 

Implanted cardioverter-defibrillators (ICDs) have been used 

to jump-start dodgy hearts back into action since the 1980s. But Sean is one of the first patients in the UK to receive a radically new type of ICD that promises to transform the lives of the thousands of Britons at risk of abnormal heartbeat, called an arrhythmia (which is thought to have caused Fabrice Muamba, the Bolton footballer, to collapse on the pitch last month). 

Conventional ICDs have extended countless lives, but they have drawbacks, as reported on these pages recently. The battery-powered devices, implanted under the collarbone, monitor the heartbeat via wires that are passed through a vein into the heart. The wires pose a risk of infection and, because heart muscle moves constantly, there is also a chance of them fracturing and needing to be replaced, the surgery for which carries a further risk of damaging heart muscle and of infection. 

In addition, about one third of the shocks given by ICDs are triggered by variations in heartbeat that pose no immediate danger to the patient but can cause anxiety and panic attacks. 

The new state-of-the-art device, called the Subcutaneous Implantable Cardioverter-Defibrillator (S-ICD) is positioned in the chest area of skin under the arm. Unlike a standard ICD, the leads are not embedded in the heart but run just under the skin, outside the rib cage. Doctors say fitting the new
S-ICD is a simpler procedure, with less potential complications. The new device is also less likely to pick up harmless electrical “noise” from the heart and trigger distressing false alarms. 

“It doesn’t appear to give the false shocks that the old one did,” explains Dr Andrew Grace, consultant cardiologist at Papworth Hospital, Cambridge, who helped develop the device. “And it’s not touching the heart, so if an infection does occur, you can take it out without any problems.” 

Studies at Papworth and in New Zealand, published in the New England Journal of Medicine in 2010, found the S-ICD 100 per cent successful in treating severe arrhythmias. 

That’s exactly what Sean, a housing repair manager, discovered when he had a second cardiac arrest last November. 

“The S-ICD saved my life,” he says. “I got up off the sofa and could suddenly feel my eyes rolling into the back of my head. Then it went dark. The device must have kicked in - I was conscious again. According to the specialists, my heart stopped for only 17 seconds. I spent one night in hospital for a check-up – very different from my first attack.” 

More than 70,000 Britons die every year from sudden cardiac death triggered by an arrhythmia. After his first collapse in March 2009, Sean was in a coma for a week, and his wife, Maria, 47, and children, Liam, 16, and Emma, 13, were warned that it was unlikely he’d pull through. A marathon veteran, he had completed a 17-mile run days earlier. He had no idea there was a problem with his heart. 

Tests revealed that he had Long QT Syndrome, a condition affecting one in 10,000, where the heart takes longer than normal to reset its electrics after each beat. 

Unlike standard ICDs, the new type cannot act as pacemakers to help synchronise weaker hearts, so they are not suitable for all patients. However, Professor Peter Weissberg, medical director for the British Heart Foundation, said they may well prove cheaper for the NHS because fitting them is simpler and they are less problematic to maintain. 

Sean was the first patient at Sheffield Northern General hospital to have the £13,000 device fitted in January 2010, and one of just 1,000 patients worldwide. "It’s given me the confidence to get on with life," he says. 

"I haven’t had any false alarms, either. I run 30 miles a week now and ran a half- marathon recently. The device has given me the security of knowing that, if I need it, my heart will get a jump-start."

 

'Universal' cancer vaccine developed

Category: By News Updates
A vaccine that can train cancer patients' own bodies to seek out and destroy tumour cells has been developed by scientists. 
cancer vaccine
cancer vaccine
The therapy, which targets a molecule found in 90 per cent of all cancers, could provide a universal injection that allows patients' immune systems to fight off common cancers including breast and prostate cancer.
Preliminary results from early clinical trials have shown the vaccine can trigger an immune response in patients and reduce levels of disease. 

The scientists behind the vaccine now hope to conduct larger trials in patients to prove it can be effective against a range of different cancers. 

They believe it could be used to combat small tumours if they are detected early enough or to help prevent the return and spread of disease in patients who have undergone other forms of treatment such as surgery. 

Cancer cells usually evade patient's immune systems because they are not recognised as being a threat. 

While the immune system usually attacks foreign cells such as bacteria, tumours are formed of the patient's own cells that have malfunctioned. 

Scientists have, however, found that a molecule called MUC1, which is found in high amounts on the surface of cancer cells, can be used to help the immune system detect tumours. 

The new vaccine, developed by drug company Vaxil Biotheraputics along with researchers at Tel Aviv University, uses a small section of the molecule to prime the immune system so that it can identify and destroy cancer cells. 

A statement from Vaxil Biotheraputics said: "ImMucin generated a robust and specific immune response in all patients which was observed after only 2-4 doses of the vaccine out of a maximum of 12 doses. 

"In some of the patients, preliminary signs of clinical efficacy were observed." 

The results are still to be formally published but if further trials prove to be successful the vaccine could be available within six years. 

As a therapeutic vaccine it is designed to be given to patients who are already suffering from cancer to help their bodies fight off the disease rather than to prevent disease in the first place. 

Cancer cells contain high levels of MUC1 as it is thought to be involved helping tumours grow. Healthy human cells also contain MUC1, but have levels that are too low to trigger the immune system after vaccination. 

When a vaccinated patient's immune system encounters cancer cells, however, the far larger concentration of MUC1 causes it to attack and kill the tumour. 

As MUC1 is found in 90 per cent of all cancers, the researchers believe it could be used to combat the growth and spread of a wide range of cancers. 

In a safety trial at the Hadassah Medical Centre in Jerusalem, ten patients suffering from multiple myeloma, a form of blood cancer, have now received the vaccine. 

Seven of the patients have now finished the treatment and Vaxil reported that all of them had greater immunity against cancer cells compared to before they were given the vaccine. 

Vaxil added that three patients are now free of detectable cancer following the treatment. 

The findings support research published in the journal Vaccine, which showed the treatment induced "potent" immunity in mice and increased their survival from cancer. 

Cancer charities have given the vaccine a cautious welcome, but warned further testing was needed before it could be approved for widespread use. 

There are currently a number of other therapeutic vaccines against cancer being tested, but they have met with limited success. 

Dr Kat Arney, science information manager at Cancer Research UK, said: "There are several groups around the world investigating treatments that target MUC1, as it's a very interesting target involved in several types of cancer. 

"These are very early results that are yet to be fully published, so there's a lot more work to be done to prove that this particular vaccine is safe and effective in cancer patients."

 

Virus hits half a million Macs: How to protect yourself against malware

Category: , By News Updates
All right, Mac users - the day of reckoning has come. 

Thanks to a well-documented flaw that Apple didn't patch for three months , a nasty piece of malware called Mac Flashback seems to have infected nearly 600,000 Macs worldwide (according to Russian security firm Dr. Web ). 

Here are three things you need to do today: 

- Check to see whether your Mac is infected by Mac Flashback. The social-networking news site Mashable has created a script that will do so for you. The instructions are on the Mashable website.
If the script does find an infection, which can be at either or both of two different places in the Mac OS X file system, removal is a bit complicated. 

You'll have to go into the Terminal app and take the Mac Flashback removal steps detailed by Finnish security firm F-Secure. 

- Update OS X with the latest security patches from Apple. Apple patched OS X 10.6 Snow Leopard and OS X Lion earlier this week, but it just updated the patch for Lion Thursday, April 5.
If you're on a PowerPC-chip-based Mac running OS X 10.5 Leopard, Apple no longer cares about you (see below). 

- Take a deep breath and say to yourself, "Steve Jobs is dead and my Mac is not immune to malware." Then install a solid anti-virus product. Today, right now, ASAP. 

The weak anti-virus software that Apple bundles into OS X 10.7 Lion doesn't cut it, and neither will the half-hearted Gatekeeper feature in the upcoming OS X 10.8 Mountain Lion. 

Take a look at the paid products reviewed by our sister site TopTenReviews, or go to the website of the British security firm Sophos and download and install their free Mac anti-virus software . 

Additionally, there are two things you probably should do: 

- Disable the Java run-time engine, if you're not using it. 

Java, the platform-independent environment used to run Web apps and perform other tasks, has too many flaws to justify its use unless it's absolutely necessary. (Apple tacitly acknowledged this when it didn't bundle Java into OS X 10.7 Lion.) Open the Java Preferences utility in Mac OS X, uncheck all selections and reboot. 

Unfortunately, some software, such as the applications in Adobe's Creative Suite, including Photoshop, Illustrator and InDesign, requires that Java be enabled. 

In that case, you'll just have to trust Apple once more, even though it was remarkably late about riding to the rescue in this instance. The Java flaw that Mac Flashback exploited was patched two months ago for Windows and Linux. 

- If you're still using a PowerPC Mac, it's time to move on. 

Apple's excellent hardware means there are millions of perfectly good PowerPC machines still out there and running well, some of them built as recently as 2006. But Apple no longer supports or releases security patches for them. It wants you to upgrade, and now you don't have a choice in the matter. 

source: http://www.securitynewsdaily.com/
 

Millions at risk as effect of anti-malaria drugs weakens

Category: , , By News Updates
Millions at risk as effect of anti-malaria drugs weakens

A deadly form of malaria has developed a resistance to the most powerful drugs used to treat the disease, putting the lives of millions of people around the world at risk. 

Tests by a team of British and Thai scientists over a 10-year period found the most dangerous species of malaria parasites, spread by mosquitoes, are becoming more resistant to the most effective treatments containing artemisinin, a drug derived from the sweet wormwood shrub. 

They discovered that Plasmodium falciparum, which was first reported in 2009 in western Cambodia, is now being found 500 miles (805 kilometers) away on the border of Thailand and Burma. 

The details of their findings and research, published in The Lancet medical journal, showed that between 2001 and 2010, the average time taken to reduce the number of parasites in the blood by half following treatment rose from 2.6 hours to 3.7 hours. 

The proportion of slow-clearing infections increased during the same period from six to 200 out of every 1,000 cases. 

Study leader Professor Francois Nosten, director of Thailand's Shoklo Malaria Research Unit, warned of a "race against time" to halt the spread of the potentially untreatable malaria. 

"We have now seen the emergence of malaria resistant to our best drugs, and these resistant parasites are not confined to western Cambodia," he said.